Neuralink gets FDA approval for human test of brain implants

Neuralink, Elon Musk's brain-implant company, announced on Thursday that it has received approval from the Food and Drug Administration (FDA) to commence the first-ever clinical study involving humans.

Since 2019, Elon Musk, the billionaire, has repeatedly anticipated that his brain-chip company would soon obtain FDA approval for human trials. However, the company's application was rejected in early 2022, and they have been addressing the agency's concerns regarding the safety of the experimental implant.

In a tweet on Thursday, Neuralink stated, "This is the outcome of the incredible work carried out by the Neuralink team in close collaboration with the FDA, and it represents an important initial step that will eventually enable our technology to assist numerous people."

Neuralink clarified that the company is not yet open for a clinical trial.

Neuralink is currently developing a brain implant with the aim of helping paralyzed individuals regain the ability to walk and potentially curing other neurological disorders.

The FDA has not provided an immediate response to Reuters' request for comment.

Musk has expressed his willingness to implant a chip into one of his own children's brains if the circumstances required it.